Anu Pansare has joined the local gBETA team. Photo via gbetastartups.com

Houston's gBETA accelerator announced new leadership in conjunction with opening enrollment for its latest cohort this week.

The early-stage program, which is a part of Wisconsin-based gener8tor, has named Anu Pansare as its new director.

Pansare has spent the last 20 years at Sugar Land-based consulting firm Volyx and has also worked with big names like Chevron, Schlumberger, and Accenture, as well as smaller startups. She's also been involved with the Houston Angel Network. She will be replacing the accelerator's inaugural director Eléonore Cluzel in the position.

As the main liaison between Houston and gener8tor's national network, Pansare will lead gBETA's third cohort of early stage startups through its free 7-week program, which is designed to help participating companies gain early customer traction and develop key metrics that will make them more marketable for future investment.

"Downtown Launchpad is an inclusive ecosystem of tools, resources, and opportunities that help founders accelerate and scale their businesses to solve humankind's boldest challenges," says Robert Pieroni, director of economic development at Central Houston, in a press release. "The addition of Anu Pansare as gener8tor's new Houston director will strengthen our commitment to entrepreneurs in Houston and will help us evolve our strategy to better serve our founders, startups, partners, and our community."

Applications for the new cohort are open online until March 13.The zero-equity, no-fee program looks for locally based startups still in the early stage of business. Five companies will be selected.

The program is hosting a virtual webinar in partnership with SCORE Houston on March 1 to discuss the program and opportunities for interested startups. Event registration is free.

Houston's gBETA presence was launched thanks to a $1.25 million grant approved by the Downtown Redevelopment Authority in 2019 with support from Central Houston, the City of Houston, and Amegy Bank. The local team has an office at the Downtown Launchpad coworking space in the Amegy Bank Building on Main.

About a year into operations, gBETA has worked with 10 local startups in two cohorts across industries — from food tourism to sports technology, artificial intelligence for home buying to skincare and prescription solutions.

Pansare will be

holding virtual office hours for local entrepreneurs to provide insight and information about gBETA's Houston Spring 2021 program. More information on the program can be found at gBETA Houston's website or email Pansare directly at anu@gener8tor.com.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”